Andrew Witty was named chief executive officer of UnitedHealth Group in February 2021.
Witty was named executive vice president of UnitedHealth Group, and chief executive officer of Optum, in March 2018 and previously served as a UnitedHealth Group company director.
From 2008 to 2017, Witty was chief executive officer and a director of the leading pharmaceutical manufacturer GlaxoSmithKline plc (GSK). He joined GSK in 1985, and prior to being named CEO, served as president of GSK Europe.
Witty is former chancellor of the University of Nottingham, a British public research university, and serves on the Singapore Prime Minister’s Research.
He became chair, Imperial College Business School Advisory Board in November 2020.
He holds honorary degrees from Exeter, Manchester and Nottingham Universities.